Global laboratory animal medicine market highlights

The global laboratory animal medicine market generated a revenue of USD 7,232.7 million in 2025 and is expected to reach USD 11,521.9 million by 2033.
The market is expected to grow at a CAGR (2026 - 2033) of 6.1% by 2033.
In terms of segment, therapeutics & preventive medicines accounted for a revenue of USD 2,009.0 million in 2025.
Therapeutics & Preventive Medicines is the most lucrative product segment registering the fastest growth during the forecast period.
In terms of region, North America was the largest revenue generating market in 2025.
Country-wise, China is expected to register the highest CAGR from 2026 to 2033.

Market revenue in 2025	USD 7,232.7 million
Market revenue in 2033	USD 11,521.9 million
Growth rate	6.1% (CAGR from 2026 to 2033)
Largest segment	Therapeutics & preventive medicines
Fastest growing segment	Therapeutics & Preventive Medicines
Historical data covered	2021 - 2024
Base year for estimation	2025
Forecast period covered	2026 - 2033
Quantitative units	Revenue in USD million
Market segmentation	Diagnostics & Health Surveillance Products, Therapeutics & Preventive Medicines, Clinical Care Devices & Equipment, Clinical & Welfare Consumables

In terms of revenue, the North America accounted for 48.1% of the global laboratory animal medicine market in 2025.
By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
By country, China is the fastest growing regional market and is projected to reach USD 849.3 million by 2033.

Therapeutics & Preventive Medicines - Laboratory Animal Medicine Market Statistics